Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven Snapinn; LIFE study group

doi:10.1016/S0140-6736(02)08090-X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Lars H Lindholm, Hans Ibsen, Björn Dahlöf, Richard B Devereux, Gareth Beevers, Ulf de Faire, Frej Fyhrquist, Stevo Julius, Sverre E Kjeldsen, Krister Kristiansson, Ole Lederballe-Pedersen, Markku S Nieminen, Per Omvik, Suzanne Oparil, Hans Wedel, Peter Aurup, Jonathan Edelman, Steven Snapinn, LIFE study group

Faculty of Medicine and Health Sciences

Research output: Contribution to journal › Article

1426 Citations (Scopus)

Original language	English
Pages (from-to)	1004-1010
Number of pages	7
Journal	The Lancet
Volume	359
Issue number	9311
DOIs	https://doi.org/10.1016/S0140-6736(02)08090-X
Publication status	Published - 2002

Access to Document

10.1016/S0140-6736(02)08090-X

http://dx.doi.org/10.1016/S0140-6736(02)08090-X

Cite this

Lindholm, L. H., Ibsen, H., Dahlöf, B., Devereux, R. B., Beevers, G., de Faire, U., Fyhrquist, F., Julius, S., Kjeldsen, S. E., Kristiansson, K., Lederballe-Pedersen, O., Nieminen, M. S., Omvik, P., Oparil, S., Wedel, H., Aurup, P., Edelman, J., Snapinn, S., & LIFE study group (2002). Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. The Lancet, 359(9311), 1004-1010. https://doi.org/10.1016/S0140-6736(02)08090-X

Lindholm, Lars H ; Ibsen, Hans ; Dahlöf, Björn ; Devereux, Richard B ; Beevers, Gareth ; de Faire, Ulf ; Fyhrquist, Frej ; Julius, Stevo ; Kjeldsen, Sverre E ; Kristiansson, Krister ; Lederballe-Pedersen, Ole ; Nieminen, Markku S ; Omvik, Per ; Oparil, Suzanne ; Wedel, Hans ; Aurup, Peter ; Edelman, Jonathan ; Snapinn, Steven ; LIFE study group. / Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. In: The Lancet. 2002 ; Vol. 359, No. 9311. pp. 1004-1010.

@article{756eeb44c6154ce686eab1a31fb4138e,

title = "Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol",

author = "Lindholm, {Lars H} and Hans Ibsen and Bj{\"o}rn Dahl{\"o}f and Devereux, {Richard B} and Gareth Beevers and {de Faire}, Ulf and Frej Fyhrquist and Stevo Julius and Kjeldsen, {Sverre E} and Krister Kristiansson and Ole Lederballe-Pedersen and Nieminen, {Markku S} and Per Omvik and Suzanne Oparil and Hans Wedel and Peter Aurup and Jonathan Edelman and Steven Snapinn and {LIFE study group} and A Coats",

year = "2002",

doi = "10.1016/S0140-6736(02)08090-X",

language = "English",

volume = "359",

pages = "1004--1010",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9311",

}

Lindholm, LH, Ibsen, H, Dahlöf, B, Devereux, RB, Beevers, G, de Faire, U, Fyhrquist, F, Julius, S, Kjeldsen, SE, Kristiansson, K, Lederballe-Pedersen, O, Nieminen, MS, Omvik, P, Oparil, S, Wedel, H, Aurup, P, Edelman, J, Snapinn, S & LIFE study group 2002, 'Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol', The Lancet, vol. 359, no. 9311, pp. 1004-1010. https://doi.org/10.1016/S0140-6736(02)08090-X

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. / Lindholm, Lars H; Ibsen, Hans; Dahlöf, Björn; Devereux, Richard B; Beevers, Gareth; de Faire, Ulf; Fyhrquist, Frej; Julius, Stevo; Kjeldsen, Sverre E; Kristiansson, Krister; Lederballe-Pedersen, Ole; Nieminen, Markku S; Omvik, Per; Oparil, Suzanne; Wedel, Hans; Aurup, Peter; Edelman, Jonathan; Snapinn, Steven; LIFE study group.

In: The Lancet, Vol. 359, No. 9311, 2002, p. 1004-1010.

Research output: Contribution to journal › Article

TY - JOUR

T1 - Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

AU - Lindholm, Lars H

AU - Ibsen, Hans

AU - Dahlöf, Björn

AU - Devereux, Richard B

AU - Beevers, Gareth

AU - de Faire, Ulf

AU - Fyhrquist, Frej

AU - Julius, Stevo

AU - Kjeldsen, Sverre E

AU - Kristiansson, Krister

AU - Lederballe-Pedersen, Ole

AU - Nieminen, Markku S

AU - Omvik, Per

AU - Oparil, Suzanne

AU - Wedel, Hans

AU - Aurup, Peter

AU - Edelman, Jonathan

AU - Snapinn, Steven

AU - LIFE study group

AU - Coats, A

PY - 2002

Y1 - 2002

U2 - 10.1016/S0140-6736(02)08090-X

DO - 10.1016/S0140-6736(02)08090-X

M3 - Article

VL - 359

SP - 1004

EP - 1010

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 9311

ER -